http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103690526-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 |
| filingDate | 2013-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103690526-B |
| titleOfInvention | One is removed malonyl azalomycin F and vitamin K3Antibacterial combination |
| abstract | The invention discloses one and remove malonyl azalomycin F and vitamin K 3 Antibacterial combination, it contains malonyl azalomycin F and vitamin K 3 . Experiment shows: remove malonyl azalomycin F and vitamin K 3 Have the antibacterial action of Synergistic, the antibacterial activity of the more independent medication of drug combination has improved 4-8 doubly; On the other hand, while obtaining identical antibacterial effect, drug combination can make dosage separately be reduced to 0.125-0.25 times of independent medication, thereby has reduced the toxic and side effect of independent medication. Show by removing malonyl azalomycin F and vitamin K 3 The antibacterial combination of composition has good drug development prospect, can be used for the medicine of preparation treatment pathogenic bacterial infection. |
| priorityDate | 2013-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.